NuVasive®, Inc.
LinkedIn YouTube Twitter Facebook

Anterior Thoracolumbar

The mid- and low-back, or thoracolumbar spine, consists of 17 vertebrae—twelve thoracic and five lumbar—as well as the sacrum. Common pathologies in the anterior (front) thoracolumbar spine include, but are not limited to, degenerative disc disease (DDD), degenerative spondylolisthesis, degenerative scoliosis, adjacent segment disease, and vertebral body tumor or trauma.  NuVasive® offers a full surgical solution portfolio with multiple systems designed for the treatment of these and other pathologies that affect the anterior thoracolumbar spine.

Experience NuVasive innovation. Choose a procedure below.

Anterior Thoracolumbar

XLIF

A minimally invasive surgical procedure performed through the side of the body utilizing proprietary neuromonitoring for treating a range of spinal pathologies.

Neuromonitoring

  • NVM5®

    Full neurological monitoring EMG/MEP/SSEP and status assessment during spine procedures

    View Indications for Use

    The NVM5® System is a medical device that is intended for intraoperative neurophysiologic monitoring during spinal surgery. The device provides information directly to the surgeon, to help assess a patient’s neurophysiologic status. NVM5® provides this information by electrically stimulating nerves via electrodes located on surgical accessories and monitoring electromyography (EMG), transcranial motor evoked potential (TceMEP) or somatosensory evoked potential (SSEP) responses of nerves.

    1. XLIF® (Detection) – The XLIF (Detection) function allows the surgeon to locate and evaluate spinal nerves, and is used as a nerve avoidance tool.
    2. Basic & Dynamic Screw Test – The Screw Test functions allow the surgeon to locate and evaluate spinal nerves by providing proximity information before, during or after bone preparation and placement of bone screws.
    3. Free Run EMG – The Free Run EMG function identifies spontaneous EMG activity of spinal nerves by continually displaying a live stream waveform of any mechanically induced myotome contractions.
    4. Twitch Test (Train of Four) – The Twitch Test Function allows the surgeon to assess moderate degrees of neuromuscular block in effect by evaluating muscle contraction following a train of four stimulation pulses.
    5. TcMEP – Transcranial stimulation techniques for motor evoked potentials are used to assess for acute dysfunction in axonal conduction of the corticospinal tract. The TcMEP function provides an adjunctive method to allow the surgeon to monitor spinal cord and motor pathway integrity during procedures with a risk of surgically induced motor injury.
    6. SSEP – The SSEP function allows the surgeon to assess sensory spinal cord function in surgical procedures during which the spinal cord is at risk.
    7. Remote Reader – The Remote Reader function provides real time remote access to the NVM5 System for a monitoring physician outside of the operating room.
    8. The Guidance function is intended as an aid for use in either open or percutaneous pedicle cannulation procedures in the lumbar spine of adult patients, and when used in conjunction with radiographic imaging and EMG, allows the surgeon to assess the angulation of system accessories relative to patient spinal anatomy for the creation of a cannulation trajectory for bone screw placement.

Access Instruments

  • MaXcess® 4 Retractor

    Retractor and instruments

    View Indications for Use

    The NuVasive® Stimulation/Dissection Instruments are indicated for tissue dissection and stimulation of peripheral motor nerves for location and identification during surgery, including spinal nerve roots.

Interbody

  • CoRoent®

    Interbody/VBR implants

    View Indications for Use

    When used as an intervertebral body fusion device: The NuVasive CoRoent® System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The System is designed for use with autogenous bone graft to facilitate fusion.

    The CoRoent L and XL platforms are intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar devices are to be used in patients who have had at least six months of non-operative treatment. The System is intended to be used with supplemental internal spinal fixation systems that are cleared by the FDA for use in the lumbar spine.

    When used as a partial Vertebral Body Replacement (VBR): The NuVasive CoRoent System may also be used as a partial vertebral body replacement device indicated for use in the thoracolumbar spine (T1 to L5) to replace a diseased or damaged vertebral body caused by tumor or fracture, to restore height of a collapsed vertebral body, and to achieve decompression of the spinal cord and neural tissues. The System is intended to be used with supplemental internal spinal fixation systems that are cleared by the FDA for use in the thoracic and lumbar spine. Allograft or autograft material may be used at the surgeon’s discretion.

Biologics

  • Osteocel® Plus

    Advanced cellular bone matrix

    View Indications for Use

    This product is restricted to homologous use for the repair, replacement or reconstruction of musculoskeletal defects.

Fixation

  • XLP® Plus

    Lateral plating system

    View Indications for Use

    The XLP® Plus Lateral Plate System is indicated for use via a lateral or anterolateral surgical approach above the bifurcation of the great vessels in the treatment of thoracic and thoracolumbar (T1-L5) spine instability or via the anterior surgical approach, below the bifurcation of the great vessels in the treatment of lumbar and lumbosacral (L1-S1) spine instability as a result of:

    1. Fracture (including dislocation and subluxation)
    2. Tumor
    3. Degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies)
    4. Scoliosis
    5. Kyphosis
    6. Lordosis
    7. Spinal stenosis or a
    8. Failed previous spine surgery.
  • Armada® System

    Posterior fixation system

    View Indications for Use

    When used as a pedicle screw fixation system, the Armada® Spinal System is intended to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following, acute and chronic instabilities or deformities of the posterior thoracic, lumbar, and sacral spine:

    1. Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies)
    2. Degenerative spondylolisthesis with objective, evidence of neurologic impairment
    3. Fracture
    4. Dislocation
    5. Scoliosis
    6. Kyphosis
    7. Spinal tumor. and/or
    8. Failed previous fusion (Pseudoarthosis)

    The Armada Spinal System is also indicated for the treatment of severe spondylolisthesis (Grades 3 and 4) of the L5-S1 vertebral joint in skeletally mature patients receiving fusion by autogenous bone graft, having the device fixed or attached to the lumbar and sacral spine (L3 to sacrum), with removal of the implants after attainment of a solid fusion. When used as an anterolateral non-pedicle screw system in the thoracic and lumbar spine, the Armada Spinal System is also intended for the following indications:

    1. Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies)
    2. Spinal stenosis
    3. Spondylolisthesis
    4. Spinal deformities
    5. Fracture
    6. Pseudoarthosis
    7.  Tumor resection and/or
    8. Failed previous fusion

XLIF Corpectomy

A minimally invasive surgical procedure for treating tumor and trauma spinal pathologies.

Neuromonitoring

  • NVM5®

    Full neurological monitoring EMG/MEP/SSEP and status assessment during spine procedures

    View Indications for Use

    The NVM5® System is a medical device that is intended for intraoperative neurophysiologic monitoring during spinal surgery. The device provides information directly to the surgeon, to help assess a patient’s neurophysiologic status. NVM5® provides this information by electrically stimulating nerves via electrodes located on surgical accessories and monitoring electromyography (EMG), transcranial motor evoked potential (TceMEP) or somatosensory evoked potential (SSEP) responses of nerves.

    1. XLIF® (Detection) – The XLIF (Detection) function allows the surgeon to locate and evaluate spinal nerves, and is used as a nerve avoidance tool.
    2. Basic & Dynamic Screw Test – The Screw Test functions allow the surgeon to locate and evaluate spinal nerves by providing proximity information before, during or after bone preparation and placement of bone screws.
    3. Free Run EMG – The Free Run EMG function identifies spontaneous EMG activity of spinal nerves by continually displaying a live stream waveform of any mechanically induced myotome contractions.
    4. Twitch Test (Train of Four) – The Twitch Test Function allows the surgeon to assess moderate degrees of neuromuscular block in effect by evaluating muscle contraction following a train of four stimulation pulses.
    5. TcMEP – Transcranial stimulation techniques for motor evoked potentials are used to assess for acute dysfunction in axonal conduction of the corticospinal tract. The TcMEP function provides an adjunctive method to allow the surgeon to monitor spinal cord and motor pathway integrity during procedures with a risk of surgically induced motor injury.
    6. SSEP – The SSEP function allows the surgeon to assess sensory spinal cord function in surgical procedures during which the spinal cord is at risk.
    7. Remote Reader – The Remote Reader function provides real time remote access to the NVM5 System for a monitoring physician outside of the operating room.
    8. The Guidance function is intended as an aid for use in either open or percutaneous pedicle cannulation procedures in the lumbar spine of adult patients, and when used in conjunction with radiographic imaging and EMG, allows the surgeon to assess the angulation of system accessories relative to patient spinal anatomy for the creation of a cannulation trajectory for bone screw placement.

Access Instruments

  • MaXcess® 4 Retractor

    Retractor and instruments

    View Indications for Use

    The NuVasive® Stimulation/Dissection Instruments are indicated for tissue dissection and stimulation of peripheral motor nerves for location and identification during surgery, including spinal nerve roots.

Vertebral Body Replacement

  • X-CORE®

    Expandable vertebral body replacement device

    View Indications for Use

    The X-Core® Adjustable VBR System is a vertebral body replacement device indicated for use in the thoracolumbar spine (T1 to L5) to replace a diseased or damaged vertebral body caused by tumor or fracture, to restore height of a collapsed vertebral body, and to achieve decompression of the spinal cord and neural tissues. The X-Core  Adjustable VBR System is intended to be used with supplemental internal spinal fixation systems that are cleared by the FDA for use in the thoracic and lumbar spine. Allograft or autograft material may be used at the surgeon’s discretion.

  • NuVasive Titanium Surgical Mesh

    Vertebral body replacement device

    View Indications for Use

    The NuVasive® Titanium Mesh is a vertebral body replacement device indicated for use in the thoracolumbar spine (T1 to L5) to replace a diseased or damaged vertebral body caused by tumor or fracture, to restore height of a collapsed vertebral body, and to achieve decompression of the spinal cord and neural tissues. The NuVasive Titanium Mesh is intended to be used with supplemental internal spinal fixation systems that are cleared by the FDA for use in the thoracic and lumbar spine. Allograft or autograft material may be used at the surgeon’s discretion.

Biologics

  • FormaGraft®

    Collagen bone graft matrix

    View Indications for Use

    Formagraft® is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides bone void filler that resorbs and is replaced by the growth of new bone during the healing process. The bone graft can be mixed with autogenous bone marrow prior to use at the physician’s discretion. In weight bearing situations, Formagraft is to be used in conjunction with internal or external fixation devices.  The fracture defect treated with Formagraft should not exceed 30 mL.

  • Osteocel® Plus

    Advanced cellular bone matrix

    View Indications for Use

    This product is restricted to homologous use for the repair, replacement or reconstruction of musculoskeletal defects.

Fixation

  • Traverse™

    Lateral plating system

    View Indications for Use

    The NuVasive Traverse® Plate System is indicated for use via a lateral or anterolateral surgical approach above the bifurcation of the great vessels in the treatment of thoracic and thoracolumbar (T1-L5) spine instability or via the anterior surgical approach, below the bifurcation of the great vessels in the treatment of lumbar and lumbosacral (L1-S1) spine instability as a result of:

    1. Fracture (including dislocation and subluxation)
    2. Tumor
    3. Degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies)
    4. Scoliosis
    5. Kyphosis
    6. Lordosis
    7. Spinal stenosis
    8. Failed previous spine surgery
  • SpheRx® II Anterior

    Anterior fixation system

    View Indications for Use

    When used as an anterolateral non-pedicle screw system in the thoracic and lumbar spine, the NuVasive SpheRx® II Spinal System is also intended for the following indications:

    1. Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies),
    2. Spinal stenosis,
    3. Spondylolisthesis,
    4. Spinal deformities,
    5.  Fracture,
    6. Pseudoarthosis,
    7.  Tumor resection, and/or
    8. Failed previous fusion.

ALIF

An anterior (from the front) procedure that involves approaching the spine through an incision in the abdomen to treat patients suffering from lower back and/or leg pain due to degenerative spine conditions.

Neuromonitoring

  • NVM5®

    Full neurological monitoring EMG/MEP/SSEP and status assessment during spine procedures

    View Indications for Use

    The NVM5® System is a medical device that is intended for intraoperative neurophysiologic monitoring during spinal surgery. The device provides information directly to the surgeon, to help assess a patient’s neurophysiologic status. NVM5® provides this information by electrically stimulating nerves via electrodes located on surgical accessories and monitoring electromyography (EMG), transcranial motor evoked potential (TceMEP) or somatosensory evoked potential (SSEP) responses of nerves.

    1. XLIF® (Detection) – The XLIF (Detection) function allows the surgeon to locate and evaluate spinal nerves, and is used as a nerve avoidance tool.
    2. Basic & Dynamic Screw Test – The Screw Test functions allow the surgeon to locate and evaluate spinal nerves by providing proximity information before, during or after bone preparation and placement of bone screws.
    3. Free Run EMG – The Free Run EMG function identifies spontaneous EMG activity of spinal nerves by continually displaying a live stream waveform of any mechanically induced myotome contractions.
    4. Twitch Test (Train of Four) – The Twitch Test Function allows the surgeon to assess moderate degrees of neuromuscular block in effect by evaluating muscle contraction following a train of four stimulation pulses.
    5. TcMEP – Transcranial stimulation techniques for motor evoked potentials are used to assess for acute dysfunction in axonal conduction of the corticospinal tract. The TcMEP function provides an adjunctive method to allow the surgeon to monitor spinal cord and motor pathway integrity during procedures with a risk of surgically induced motor injury.
    6. SSEP – The SSEP function allows the surgeon to assess sensory spinal cord function in surgical procedures during which the spinal cord is at risk.
    7. Remote Reader – The Remote Reader function provides real time remote access to the NVM5 System for a monitoring physician outside of the operating room.
    8. The Guidance function is intended as an aid for use in either open or percutaneous pedicle cannulation procedures in the lumbar spine of adult patients, and when used in conjunction with radiographic imaging and EMG, allows the surgeon to assess the angulation of system accessories relative to patient spinal anatomy for the creation of a cannulation trajectory for bone screw placement.

Interbody

  • CoRoent®

    Interbody/VBR implants

    View Indications for Use

    When used as an intervertebral body fusion device: The NuVasive CoRoent® System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The System is designed for use with autogenous bone graft to facilitate fusion.

    The CoRoent L and XL platforms are intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar devices are to be used in patients who have had at least six months of non-operative treatment. The System is intended to be used with supplemental internal spinal fixation systems that are cleared by the FDA for use in the lumbar spine.

    When used as a partial Vertebral Body Replacement (VBR): The NuVasive CoRoent System may also be used as a partial vertebral body replacement device indicated for use in the thoracolumbar spine (T1 to L5) to replace a diseased or damaged vertebral body caused by tumor or fracture, to restore height of a collapsed vertebral body, and to achieve decompression of the spinal cord and neural tissues. The System is intended to be used with supplemental internal spinal fixation systems that are cleared by the FDA for use in the thoracic and lumbar spine. Allograft or autograft material may be used at the surgeon’s discretion.

Biologics

  • Osteocel® Plus

    Advanced cellular bone matrix

    View Indications for Use

    This product is restricted to homologous use for the repair, replacement or reconstruction of musculoskeletal defects.

Interfixated Device

  • Brigade®

    Standalone ALIF

    View Indications for Use

    When used as an intervertebral body fusion device: The Brigade® System is a standalone system indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (DDD) at one or two contiguous levels in the lumbar spine (L2 to S1). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies. DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved levels. These patients may have had a previous non-fusion spinal surgery at the involved level(s). The Brigade System is intended for use with autograft. Patients must have undergone a regimen of at least six (6) months of non-operative treatment prior to being treated with the CoRoent® XLR-Standalone System.

    When used as a partial Vertebral Body Replacement (VBR): The Brigade System is a standalone system indicated for use in the thoracolumbar spine (T1 -L5) for partial replacement of a diseased vertebral body resected or excised for the treatment of tumors, to achieve anterior decompression of the spinal cord and neural tissues, and to restore the height of a collapsed vertebral body. The BrigadeSystem is also indicated for treating fractures of the thoracic and lumbar spine. The Brigade System is intended to be used with autograft or allograft.

  • Envoy™

    Implant delivery system

    View Indications for Use

    NuVasive® instruments are manually operated devices indicated for use during spinal surgical procedures.

Fixation

  • Halo®

    Anterior lumbar plate

    View Indications for Use

    The NuVasive Halo® II Anterior Lumbar Plate System is indicated for use via a lateral or anterolateral surgical approach above the bifurcation of the great vessels in the treatment of thoracic and thoracolumbar (T1-L5) spine instability or via the anterior surgical approach, below the bifurcation of the great vessels in the treatment of lumbar and lumbosacral (L1-S1) spine instability as a result of:

    1. Fracture (including dislocation and subluxation)
    2. Tumor
    3. Degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies)
    4. Scoliosis
    5. Kyphosis
    6. Lordosis
    7. Spinal stenosis
    8. Failed previous spine surgery

Note: References to specific products as components of an XLIF procedure or other surgical procedure/approach do not imply that such products have FDA regulatory clearance or approval for all of the pathologies or indications described. The surgical procedures described on this website may not require the use of some or all of the NuVasive products found on this website. Please refer to the professional product labeling of the NuVasive products for their specific FDA cleared or approved indications of use.